Zůstane pohlavní styk i nadále preferovaným způsobem lidské reprodukce?

doc. MUDr. Jaroslav Zvěřina, CSc.

Psychiatr. praxi 2018; 19(3): 91  

New psychoactive substances in Europe and Czech Republic

Mgr. Kateřina Grohmannová, doc. MUDr. Viktor Mravčík, Ph.D.

Psychiatr. praxi 2018; 19(3): 96-100 | DOI: 10.36290/psy.2018.020  

New psychoactive substances (NPS) have appeared on the European drug scene for the last 15 years. In the Czech Republic, theirprevalence is noticeable since 2010. NPS represent various chemical groups with various effects imitating the effects of illicitdrugs. They are supplied as legal highs, research chemicals, food supplements or medicinal products. The supply of NPS on thedrug market is changing quite rapidly. Situation on availability of NPS is being monitored by the early warning system. In 2016, 44NPS were newly reported in the Czech Republic, most commonly synthetic cathinones. Serious health consequences are mostlyassociated with synthetic...

Resistance in maintenance treatment of bipolar disorder

MUDr. Tomáš Novák, Ph.D.

Psychiatr. praxi 2018; 19(3): 102-105 | DOI: 10.36290/psy.2018.021  

Effective and well-tolerated maintenance treatment is a major goal in a management of bipolar disorder (BD), but is still achievedonly in a minority of the patients. One of the main potentially reversible factor influencing treatment outcome is a poor adherence.The implementation of psychoeducation and other psychosocial interventions is therefore considered to be an importatnt stepin long-term treatment. Although lithium remains first choice as maintenance treatment for BD following the most of guidelines,in clinical practice is still used insufficiently. On the other hand, in spite of limited evidence, a substantial part of patients receiveantidepressants...

Mental symptoms in patients who suffer from multiple sclerosis

MUDr. Štěpánka Machová, MUDr. Eva Kadlecová, CSc.

Psychiatr. praxi 2018; 19(3): 106-110 | DOI: 10.36290/psy.2018.022  

Multiple sclerosis is a severe demyelinating disease. The disease itself and the side effects of introduced pharmacotherapy canpossibly contribute to developing mental disorders in patients with multiple sclerosis. The most common mental symptoms presentingin multiple sclerosis patients is depression, anxiety, pathological crying and laughing, a cognitive deficit. Rarely, patientsmay present psychotic symptoms or mania. The aim of this article is to raise the awareness about significant yet often missedoccurrence of mental disorders in patients with multiple sclerosis. The article also lists the treatment options for these disorders.Timely and adequate...

Depression in neurologic disorders, incidence and its treatment

MUDr. Sylva Racková

Psychiatr. praxi 2018; 19(3): 111-115  

Depression belons among the most frequent comorbities in neurologic disorders. Its prevalence is higher and depression influencesthe course of neurologic disorders. There is very important the right choice of antidepressant treatment according toefficacy and tollerability in the treatment of depression in neurologic disorders.

Sleep disorders and their treatment in elderly

MUDr. Eva Miletínová, M.Sc., MUDr. Jitka Bušková, Ph.D.

Psychiatr. praxi 2018; 19(3): 116-122 | DOI: 10.36290/psy.2018.024  

Sleep issues are common in older patients. In patients aged 65 years and above we generally treat both primary sleep disordersand sleep disturbances that are related to comorbid internal or psychiatric disorders or occur due to medication used. The aimof this paper is to describe physiological changes of sleep in elderly patients, outline the most common sleep disorders in thiscohort along with current treatment options.

Obstructive sleep apnea from a psychiatric viewpoint

MUDr. Jakub Vaněk

Psychiatr. praxi 2018; 19(3): 124-127 | DOI: 10.36290/psy.2018.025  

Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder with a lifetime prevalence of 2–14% in theadult population. The hallmark of the disease are recurrent apneic episodes caused by a closure of the upper airways at the endof expiration. The most common cause of the closure is the accumulation of fat tissue around the pharynx and the soft palate.Apneic episodes lead to activation of the sympathetic nervous system, fragmentation of sleep, and its inadequate quality. Diagnostictests are performed in sleep laboratories, and treatment consists in lifestyle measures, weight reduction, and in deliveringoverpressure in the...

Using pregabalin at patient with schizophrenia.

MUDr. Lucie Buryšková

Psychiatr. praxi 2018; 19(3): 128-130 | DOI: 10.36290/psy.2018.026  

Anxiety at patients with schizophrenia decrease the quality of life, one of the possible eventuality of the treatment is pregabalinwith its unique functioning. The case report of pacient with schizophrenia, where pregabalin help reduce the anxienty.